Skip to main content

Faculty Profile

Kevin GareyKevin W. Garey

Professor of Pharmacy Practice
Robert L. Boblitt Endowed Professor of Drug Discovery
Department Chair
Pharmacy Practice and Translational Research

University of Houston College of Pharmacy
Health 2, Room 4039
4349 Martin Luther King Boulevard
Houston, TX 77204-5039

Contact: - 832-842-8386


Dr. Garey's research interests are centered on clinical and translational research in healthcare associated infections including healthcare-related infections, candidemia, and Clostridium difficile infection.

  • Bachelor of Science in Pharmacy, 1991-95, Dalhousie University, Halifax, Nova Scotia
  • Doctorate of Pharmacy, 1995-97, University at Buffalo, Buffalo, NY
  • M.S. in Biometry, 2007, University of Texas School of Public Health, Houston, TX

Google Scholar Profile
  • KW Garey, M Rege, MP Pai, DE. Mingo, KJ Suda, RS Turpin, and DT Bearden. Time until initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006;43 (1 July):25-31 PMID: 16758414
  • KW Garey, ZD Jiang, S Ghantoji, VH Tam, V Arora, and HL DuPont. A Common Polymorphism in the Interleukin-8 Gene Promoter is Associated with Increased Risk for Recurrent Clostridium difficile Infection. Clin Infect Dis 2010;51(12):1406-1410 PMID: 21058913
  • KW Garey, S Ghantoji, DN Shah, M Habib, V Arora, ZD Jiang, and HL DuPont. A randomized double-blind placebo-controlled pilot study to assess the effect of rifaximin to prevent recurrent diarrhea in patients with Clostridium difficile infection. J Antimicrob Chemother 2011;66(12):2850-5 PMID: 21948965
  • ND Beyda, J John, A Kilic, MJ Alam, TM Lasco, KW Garey. FKS mutant Candida glabrata; risk factors and outcomes in patients with candidemia. Clin Infect Dis 2014:15;59(6):819-25. PMID: 24879785
  • E Basseres, BT Endres, M Khaleduzzaman, F Miraftabi, MJ Alam, RJ Vickers, KW Garey. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother 2016;71(5):1245-51. PMID: 26895772
  • BT Endres, E Bassères, M Khaleduzzan1, MJ Alam, L Chesnel, and KW Garey. Evaluating the Effects of Surotomycin Treatment on C. difficile Toxin A and B Production, Immune Response, and Morphologic Changes. Antimicrob Agents Chemother 2016 May 23;60(6):3519-23. PMID: 27021314
  • KW Garey, SL Aitken, L Gschwind, S Goddu, Y Xie, C Duff, F Barbut, DN Shah, and HL DuPont. Development and Validation of a Clostridium difficile Health-related Quality of Life Questionnaire. J Clin Gastro 2016 Sep;50(8):631-7. PMID 26796081
  • MJ Alam, ST Walk, BT Endres, E Basseres, M Khaleduzzaman, J Amadio, WL Musick, JL Christensen, J Kuo, RL Atmar, and KW Garey. Community environmental contamination of toxigenic Clostridium difficile. Open Forum Infect Dis 2017 Feb 10;4(1):ofx018. doi: 10.1093/ofid/ofx018. eCollection 2017 Winter PMID: 28480289
  • LC McDonald, DN Gerding, S Johnson, JS. Bakken, KC Carroll, SE Coffin, ER Dubberke, KW Garey, CV Gould, C Kelly, Loo, JS Sammons, TJ Sandora, MH Wilcox. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987-94. PMID: 29462280
  • KR Reveles, KM Dotson, A Gonzales-Luna, D Surati, BT Endres, MJ Alam, KW Garey. Clostridioides (formerly Clostridium) difficile infection during hospitalization increases the likelihood of non-home patient discharge. Clin Infect Dis. 2019 May 17;68(11):1887-1893. PMID:30204878
  • TJ Carlson, BT Endres, JL Pham, AJ Gonzales-Luna, FS Alnezary, K Nebo, J Miranda, C Lancaster, E Bassères, K Begum, MJ Alam, KR Reveles, KW Garey. Eosinopenia and binary toxin increases mortality in hospitalized patients with Clostridioides difficile infection. Open Forum Infect Dis 2020 Jan 4;7(1):ofz552. doi: 10.1093/ofid/ofz552. PMID: 31993458;
  • AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, J Miranda, C Lancaster, S Walk, S Tupy, K Begum, MJ Alam, KW Garey. PCR ribotypes of Clostridioides difficile Across Texas from 2011-2018 including Emergence of Ribotype 255. Emerg Microbes Infect 2020; 9(1):341-347. PMID 32037964
  • Garey KW, Begum K, Lancaster C, Gonzales-Luna AJ; Bui D, Mercier J, Corinne, SY, Ducharme MP, Hu M, Vince B, Silverman MH, Alam MJ, Kankam M. Randomized, Double blind, Placebo controlled, Single and Multiple Ascending Dose Phase 1 Study to Determine the Safety, Pharmacokinetics, Food, and Fecal Microbiome Effects of Ibezapolstat Administered Orally to Healthy Subjects. J Antimicrob Chemother 2020 Sep 6:dkaa364. doi: 10.1093/jac/dkaa364. PMID: 32892222
  • AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, KM Dotson, C Lancaster, K Begum, MJ Alam, JG Hurdle, KW Garey. Reduced susceptibility to metronidazole is associated with initial clinical failure in Clostridioides difficile infection. Open Forum Infect Dis, 2021 July 8; ofab365. Doi: 10.1093/ofid/ofab365 PMID: 34381844
  • S Johnson, V Lavergne, AM Skinner, AJ Gonzales-Luna, KW Garey, CP Kelly, MH Wilcox. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021 Jun 24:ciab549. doi: 10.1093/cid/ciab549..PMID: 34164674

Awards & Honors

  • Research Fellowship Award, University of Illinois at Chicago 2000
  • SIDP Pharmacists Research Award, 2000
  • ACCP ID-PRN Resident/Fellow Research Award, 2000
  • Rho Chi member, 2003
  • Who's Who in Medicine and Healthcare, 2003
  • University of Houston College of Pharmacy Rho Chi Teacher Excellence Award, 2003
  • University of Houston College of Pharmacy Faculty Teaching Excellence Award, 2003
  • Finalist, University of Houston Faculty Teaching Award, 2004
  • University of Houston College of Pharmacy Rho Chi Teacher Excellence Award, 2005
  • University of Houston College of Pharmacy Faculty Preceptor Award, 2005
  • Selected Best Papers in Mycology ICAAC 2006, San Francisco, CA, 2006
  • University of Houston College of Pharmacy Faculty Research Excellence Award, 2007
  • SIDP Impact Paper in Infectious Diseases Pharmacotherapy Award, 2007
  • ASHP Drug Therapy Research Award, 2007
  • Best Review Paper of 2009, Journal of Hospital Infection, 2009
  • ASHP Best Practices Award in Health-System Pharmacy, 2010
  • Fellow, American Society of Health-System Pharmacy, 2012
  • SIDP Impact Paper in Infectious Diseases Pharmacotherapy Award, 2012
  • University of Houston PLS Faculty Leadership Award, 2013
  • Top 10 Papers in Mycology, ICAAC 2014, Washington, DC, 2014
  • Rho Chi Bergy Lecture Recipient, West Virginia University Morgantown, WV, 2017
  • IDSA Antimicrobial Stewardship Center of Excellence, Baylor St. Luke's Medical Center, 2020
  • IDSA Fellow, 2020
  • ACCP Fellow, 2021
  • ACCP Russell R. Miller Award, 2022
  • Innovator Award, Peggy Lillis Foundation for C. Diff Education & Advocacy, 2023